Melbourne Blood Specialists Logo

Our doctors

Dr Ali Bazargan

Dr Ali Bazargan Dr Bazargan is a Haematology Consultant at St Vincent’s Hospital. He has broad expertise across the field of benign and malignant haematology, with a special emphasis on clotting/bleeding disorders, lymphomas, myelodysplastic syndrome, myeloproliferative disorders and FBE abnormalities.

Dr Bazargan obtained his MD degree in 1992 and carried out his basic & advanced physician and haematology training at Monash Medical Centre, St Vincent’s Hospital and Peter MacCallum Cancer Centre.

He is actively involved in clinical trials in a wide range of haematological malignancies as principal investigator or associate investigator at St Vincent’s Public Hospital.

As a member of the Haematology Society of Australia & New Zealand, American Society of Haematology, Australasian Leukaemia & Lymphoma Group and European Haematology Association, Dr Bazargan is committed to providing individualized clinical care for patients with blood disorders and is well known for his dedication and compassion in achieving the best possible outcome for his patients.

Dr Bazargan holds public hospital appointments at St Vincent’s Hospital and private appointments at St Vincent’s Private and Epworth Richmond.

Assoc Prof. Constantine (Con) Tam

Dr Constantine (Con) Tam Associate Professor Constantine (Con) Tam is the Director of Haematology at St Vincent’s Hospital, and Clinical Lead for CLL and Indolent Lymphoma at the Victorian Comprehensive Cancer Center. He graduated from the University of Melbourne in 1998 completing his haematology training in Melbourne and at the MD Anderson Cancer Centre in USA. Dr Tam is internationally recognized for his expertise in blood cancers, especially in non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Dr Tam believes that engaging in clinical trials is the best way for patients to get early access to the most promising new treatments for cancer. He is principal investigator on multiple local and international studies. Dr Tam publishes extensively in top-tiered international journals and is an editorial board member of the Leukemia & Lymphoma journal.

Dr Tam is committed to ensuring that Australian patients suffering from blood cancer receive the best treatment available anywhere in the world.

Assoc Prof. Hang Quach

Dr Hang Quach Associate Professor Hang Quach is a consultant clinical and laboratory Haematologist and Director of Haematology Clinical Trials at St Vincent’s Hospital Melbourne. She is a graduate of the University of Melbourne. A/Prof. Quach’s career in haematology is accentuated by her strong involvement in both clinical and laboratory research, which has resulted in many publications in high impact medical journals and attracted many peer-reviewed grants for research.

She is passionate about improving the standard of care for patients with blood cancers in Australia, not only through research, but also through her active roles on a number of national and international boards and committees, through which she has lead a number of published national treatment guidelines on blood disorders. Dr Quach is currently the co-chair of the Myeloma Disease Group Committee of the ALLG (Australian Lymphoma and Leukaemia Group). She also serves as a councillor of the Specialist Medical Review Council to the Australian Minister of Veterans’ Affairs and leads the development and update of the Australian National Treatment Guideline for Multiple Myeloma, as part of her role on the Myeloma Scientific Advisory Group (MSAG) for Myeloma Australia.

Dr Quach’s area of expertise is malignant haematological disorders in particular multiple myeloma, lymphoma, myeloproliferative diseases, myelodysplasia and leukaemia. Dr Quach is well known for her dedication and willingness to go to great lengths to achieve the optimal outcome for her patients.

Dr Shuhying Tan

Dr Shuhying Tan Dr Tan is a clinical and laboratory haematologist affiliated with St Vincent’s Public and Private hospitals. She graduated from the University of Melbourne, and subsequently completed her haematology training in 2013 with joint fellowships to the Royal Australasia College of Physicians and Royal College of Pathologists of Australasia.

Dr Tan is experienced in a wide range of benign and malignant blood disorders. She has a special interest in malignant haematological disorders, particularly myelodysplasia and lymphoma, and this has inspired her to undertake PhD translational research at St Vincent’s Institute of Medical Research and St Vincent’s Hospital.

In 2014, Dr Tan was awarded the Leukaemia Foundation Clinical PhD scholarship to conduct research into the molecular biology and novel targeted therapy in myelodysplastic syndromes. She hopes to improve treatment options and outcomes in patients with blood cancers through personalised and targeted therapy.

Dr Tan consults on all areas of haematology and currently sees patients at East Melbourne and Niddrie (NorthWest Specialist Centre).

Dr Matthew Ku

Dr Matthew Ku Dr Ku is a Clinical and Laboratory Haematologist at St Vincent's Hospital with a special interest in malignant haematology, particularly lymphoma and myelodysplastic/myeloproliferative diseases. He also has experience in clotting and bleeding disorders. 

After graduating from Monash University, Dr Ku completed his haematology training and was admitted as a Fellow by the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia in 2012. He went on to complete a PhD investigating novel oncogenic mechanisms in a subtype of acute myeloid leukaemia and attained a Specialist Certificate in Clinical Research (Oncology), both through the University of Melbourne. He obtained extensive postdoctoral experience in managing complex patients on clinical studies by completing a Lymphoma/CLL/Myeloma Fellowship, acting as a Principal as well as an Associate investigator on many international trials.   

Apart from having multiple publications in peer reviewed journals, Dr Ku has also presented at both national and international haematology conferences. In addition, he has ongoing involvement with the Leukaemia Foundation as an invited speaker for the Lymphoma Teleconference Forums which provides him with the privilege of educating patients living with lymphoma.

Dr Ku is committed to providing the highest standard of care to all his patients through dedication, compassion and evidence based medicine.